Redeye comments on Raketech’s Q2-results where topline was somewhat softer than expected while EBITD...
Redeye comments on Verve Group’s preliminary Q2 2024 numbers, which came in stronger than expected, ...
Net sales without EUR 12.8m one-of item was close to our expectation of EUR 142m in Q2.
Aspo’s Q2 results were mostly as expected as ESL’s profitability topped estimates while Telko fell s...
Ahead of Taaleri's half-year financial report, due on 20 August, we keep our underlying estimates in...
Redeye provides updated estimates and valuation following Physitrack’s Q2 report.
Redeye comments on EG7’s Q2-results which were in line with the preliminary numbers released on July...
Q2e: US operations stable, Germany still struggling We expect Ferronordic to report Q2 net sales of ...
Redeye gives its preview on OssDsign’s Q2 2024 report, due on August 20.
Redeye retains its positive view of Fortnox despite Eklund stepping down as CEO.
Redeye is positive to Bredband2’s acquisition of Bredbandsson, adding about 0.
Redeye expects Smart Eye's Q2, due 21 August, to show a 42% y/y sales growth and a mere SEK4m EBITDA...
Redeye leaves its initial take on Physitrack’s Q2 figures, which overall was line with our expectati...
Redeye further comments on Sivers' plans to merge its Photonics business with a US-listed SPAC.
Försäljningstillväxten fortsätter starkt EQL Pharma ökade de återkommande intäkterna med 47,3 procen...
Sales of ~SEK 20m, but with negative margins This afternoon, Bredband2 announced the acquisition of ...
Net sales came in 4% above our forecast, while adjusted EBITDA was 1% below our expectation for Q2.
Earnings miss driven by one-offs, AUM below ABGSCe Adjusting for the Flowbank impairment and the FTX...
Redeye updates its estimates and fair value range following CTEK’s strong Q2 report published last F...
Suominen's Q2 earnings fell slightly short of Vara consensus expectations, which leaves some uncerta...
